New product development in boiler-related, water treatment, medical, and food-related fields
First written in FY2016. 23 of 28 entries say "Restated". Latest entry: FY2026.
30 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Following amendments to the relevant regulations, which increased the allowable capacity of compact once-through boilers from the previous limit of 200kW to 600kW, the company developed the AE-900A electric compact once-through boiler. With a rated evaporation capacity of 900kg/h, the unit provides sufficient output for use as an industrial boiler, and sales are scheduled to begin during fiscal 2026.」
The company developed the AE-900A electric compact once-through boiler, with a rated evaporation capacity of 900kg/h and sales scheduled to begin during fiscal 2026, presenting specific development results and plans. - FY2026-H1RestatedAnnual report
「Total R&D expenses for the interim consolidated fiscal period were ¥2,278 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated fiscal period.」
The company recorded R&D expenses of ¥2,278 million, while explaining that there were no material changes in the status of its R&D activities. - FY2024AdvancedAnnual report
「The company commercialized a highly efficient hydrogen-fired once-through boiler capable of hydrogen-only combustion and low NOx emissions, with a rated evaporation capacity of 2 T/H and no CO2 emissions. Boiler efficiency rose significantly from 95% for the previous model to 105%, and the boiler received Tokyo's low-NOx certification.」
The company disclosed R&D results including commercialization of a hydrogen-only combustion boiler, improved efficiency and low-NOx certification. - FY2024-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥1,564 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the consolidated fiscal year.」
The company disclosed R&D expenses of ¥1,564 million for the cumulative second quarter, stating that there were no material changes in its R&D activities. - FY2024-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥671 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the consolidated fiscal year.」
The company disclosed R&D expenses of ¥671 million for the cumulative first quarter, stating that there were no material changes in its R&D activities. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥2,165 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the consolidated fiscal year.」
The company disclosed total R&D expenses of ¥2,165 million for the cumulative third quarter, stating that there were no material changes in its R&D activities. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥1,391 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the consolidated fiscal year.」
The company disclosed total R&D expenses of ¥1,391 million for the cumulative second quarter, stating that there were no material changes in its R&D activities. - FY2023-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥655 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the consolidated fiscal year.」
The company disclosed total R&D expenses of ¥655 million for the first quarter, stating that there were no material changes in its R&D activities. - FY2022-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥1,961 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the consolidated fiscal year.」
The company disclosed R&D expenses of ¥1,961 million for the cumulative third quarter, stating that there were no material changes in its R&D activities. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥1,333 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the consolidated fiscal year.」
The company disclosed R&D expenses of ¥1,333 million for the cumulative second quarter, stating that there were no material changes in its R&D activities. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥480 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the consolidated fiscal year.」
The company disclosed total R&D expenses of ¥480 million for the first quarter, stating that there were no material changes in its R&D activities. - FY2021AdvancedAnnual report
「The main R&D activities, results and R&D expenses for the consolidated fiscal year are as follows.」
The company invested ¥3,165 million in R&D and disclosed development results, commercialization and demonstrations across multiple fields, including hydrogen-fired compact boilers, fuel cells, waste-heat recovery systems, water-making systems, sterilizers, food-processing machinery and water-treatment systems. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥2,148 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the consolidated fiscal year.」
The company disclosed total R&D expenses of ¥2,148 million for the cumulative third quarter, stating that there were no material changes in its R&D activities. - FY2021-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year totaled ¥1,367 million. There were no significant changes in the status of our Group’s research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company disclosed total R&D expenses of ¥1,367 million for the cumulative second quarter, stating that there were no material changes in its R&D activities. - FY2021-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the current consolidated fiscal year totaled ¥684 million. There were no significant changes in the status of our Group’s research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company stated that there were no significant changes in its research and development activities and disclosed total research and development expenses of ¥684 million for the first quarter of the current fiscal year. - FY2020AdvancedAnnual report
「For once-through boilers, we have worked to improve boiler efficiency and developed oil-fired boilers with improved energy-saving performance under actual operating conditions, as well as high-efficiency boilers capable of supporting business continuity planning (BCP) and future areas with gas pipeline infrastructure by switching between gas and oil fuels with a switch. We are also working to develop and expand our product lineup of hydrogen-combustion boilers for a future hydrogen society.」
The company disclosed development results and new product offerings focused on energy efficiency, BCP, and a hydrogen society, including high-efficiency oil-fired boilers, gas/oil dual-fuel boilers, and hydrogen-combustion boilers. - FY2020-Q3RestatedAnnual report
「Research and development expenses for the cumulative third quarter of the current consolidated fiscal year totaled ¥2,624 million. There were no significant changes in the status of our Group’s research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company stated that there were no significant changes in its research and development activities and disclosed research and development expenses of ¥2,624 million for the cumulative third quarter. - FY2020-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year totaled ¥1,497 million. There were no significant changes in the status of our Group’s research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company stated that there were no significant changes in its research and development activities and disclosed total research and development expenses of ¥1,497 million for the cumulative second quarter of the current fiscal year. - FY2020-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the current consolidated fiscal year totaled ¥629 million. There were no significant changes in the status of our Group’s research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company stated that there were no significant changes in its research and development activities and disclosed total research and development expenses of ¥629 million for the first quarter of the current fiscal year. - FY2019-Q3RestatedAnnual report
「In addition, we are advancing the development of new services and energy-saving products by leveraging the latest information technology, including IoT,」
In addition to the existing policy of developing new products in the areas of heat, water, the environment, medical care, and food, the company is advancing the development of new services and energy-saving products using the latest information technology, including IoT. - FY2019-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year totaled ¥1,839 million. There were no significant changes in the status of our Group’s research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company stated that there were no significant changes in its research and development activities and disclosed research and development expenses of ¥1,839 million for the cumulative second quarter of the current consolidated fiscal year. - FY2019-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the current consolidated fiscal year totaled ¥931 million. There were no significant changes in the status of our Group’s research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company stated that there were no significant changes in its research and development activities and disclosed total research and development expenses of ¥931 million for the first quarter of the current fiscal year. - FY2018-Q3RestatedAnnual report
「Research and development expenses for the cumulative third quarter of the current consolidated fiscal year totaled ¥1,995 million. There were no significant changes in the status of our Group’s research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company stated that there were no significant changes in its research and development activities and disclosed research and development expenses of ¥1,995 million for the cumulative third quarter of the current consolidated fiscal year. - FY2018-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the current consolidated fiscal year totaled ¥631 million. There were no significant changes in the status of our Group’s research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company stated that there were no significant changes in its research and development activities and reported total research and development expenses of ¥631 million for the quarter. - FY2017RestatedAnnual report
「Our Group is committed to researching and developing proprietary new technologies ahead of its peers, centered on once-through boilers. In fields other than boilers, based on heat energy utilization, water treatment, and vacuum technologies, we are developing new products including steam-driven air compressors, supercooled water systems, vacuum cooling systems, sterilization systems, medical washing and drying systems, ballast water treatment equipment, water softeners, pure water systems, filtration systems, and fuel cells.」
New product development continues in fields beyond boilers, including water treatment, medical, food, and environmental applications, and total research and development expenses for the fiscal year were ¥2,754 million. - FY2017-Q3RestatedAnnual report
「There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
The company stated that there were no significant changes in its research and development activities. - FY2017-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year totaled ¥1,135 million. There were no significant changes in the status of our Group’s research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company stated that there were no significant changes in its research and development activities and reported research and development expenses of ¥1,135 million for the cumulative quarter. - FY2016First statedAnnual report
「Our Group is committed to researching and developing proprietary new technologies ahead of its peers, centered on once-through boilers. In fields other than boilers, based on heat energy utilization, water treatment, and vacuum technologies, we are developing new products including steam-driven air compressors, supercooled water systems, vacuum cooling systems, sterilization systems, medical washing systems, ballast water treatment equipment, water softeners, electrodeionization pure water systems, filtration systems, and fuel cells.」
Total research and development expenses were ¥2.6 billion, and product development has been expanded into several fields beyond boilers.